137 Stereotactic Boost and Short-Course Radiotherapy for P16-Associated Oropharynx Cancer (Short-Opc): First Planned Interim Safety Analysis from a Randomized Phase Ii Trial
Ng S, Fuller D, Garden A, Rosenthal D, Phan J, Nguyen-Tan P, Yuan Y, Filion E, Soulieres D, Christopoulos A, Hutcheson K, Lee A, Bahig H. 137 Stereotactic Boost and Short-Course Radiotherapy for P16-Associated Oropharynx Cancer (Short-Opc): First Planned Interim Safety Analysis from a Randomized Phase Ii Trial. Radiotherapy And Oncology 2023, 186: s63. DOI: 10.1016/s0167-8140(23)89228-3.Peer-Reviewed Original Research